Trial Profile
Prospective study of Velpatasvir investigating antiviral activity against signature NS5A resistance associated variants in Hepatitis C patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Dec 2015
Price :
$35
*
At a glance
- Drugs Velpatasvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 19 Dec 2015 New trial record